chr16-55493770-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004530.6(MMP2):​c.1472+477A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.791 in 152,198 control chromosomes in the GnomAD database, including 48,195 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.79 ( 48195 hom., cov: 33)

Consequence

MMP2
NM_004530.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.294

Publications

19 publications found
Variant links:
Genes affected
MMP2 (HGNC:7166): (matrix metallopeptidase 2) This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
MMP2 Gene-Disease associations (from GenCC):
  • multicentric osteolysis, nodulosis, and arthropathy
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • multicentric osteolysis-nodulosis-arthropathy spectrum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.865 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004530.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMP2
NM_004530.6
MANE Select
c.1472+477A>G
intron
N/ANP_004521.1
MMP2
NM_001127891.3
c.1322+477A>G
intron
N/ANP_001121363.1
MMP2
NM_001302508.1
c.1244+477A>G
intron
N/ANP_001289437.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMP2
ENST00000219070.9
TSL:1 MANE Select
c.1472+477A>G
intron
N/AENSP00000219070.4
MMP2
ENST00000437642.6
TSL:1
c.1322+477A>G
intron
N/AENSP00000394237.2
MMP2
ENST00000570308.5
TSL:1
c.1244+477A>G
intron
N/AENSP00000461421.1

Frequencies

GnomAD3 genomes
AF:
0.791
AC:
120338
AN:
152080
Hom.:
48168
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.660
Gnomad AMI
AF:
0.866
Gnomad AMR
AF:
0.806
Gnomad ASJ
AF:
0.837
Gnomad EAS
AF:
0.788
Gnomad SAS
AF:
0.888
Gnomad FIN
AF:
0.876
Gnomad MID
AF:
0.709
Gnomad NFE
AF:
0.845
Gnomad OTH
AF:
0.780
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.791
AC:
120416
AN:
152198
Hom.:
48195
Cov.:
33
AF XY:
0.796
AC XY:
59230
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.660
AC:
27353
AN:
41464
American (AMR)
AF:
0.806
AC:
12335
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.837
AC:
2906
AN:
3472
East Asian (EAS)
AF:
0.788
AC:
4073
AN:
5170
South Asian (SAS)
AF:
0.887
AC:
4290
AN:
4834
European-Finnish (FIN)
AF:
0.876
AC:
9300
AN:
10614
Middle Eastern (MID)
AF:
0.724
AC:
213
AN:
294
European-Non Finnish (NFE)
AF:
0.845
AC:
57508
AN:
68028
Other (OTH)
AF:
0.780
AC:
1648
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1240
2481
3721
4962
6202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.829
Hom.:
96623
Bravo
AF:
0.780
Asia WGS
AF:
0.831
AC:
2884
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.1
DANN
Benign
0.38
PhyloP100
-0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183112; hg19: chr16-55527682; API